标题
The Adolescent and Young Adult with Cancer: State of the Art - Bone Tumors
作者
关键词
Osteosarcoma, Ewing sarcoma, Bone tumor, Molecular biology, Targeted therapies
出版物
Current Oncology Reports
Volume 15, Issue 4, Pages 296-307
出版商
Springer Nature
发表日期
2013-05-20
DOI
10.1007/s11912-013-0321-9
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Ecteinascidin 743 Interferes with the Activity of EWS-FLI1 in Ewing Sarcoma Cells
- (2015) Patrick J. Grohar et al. NEOPLASIA
- Gemcitabine With or Without Docetaxel and Resection for Recurrent Osteosarcoma
- (2013) Yasmin Gosiengfiao et al. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
- FHL2 Silencing Reduces Wnt Signaling and Osteosarcoma Tumorigenesis In Vitro and In Vivo
- (2013) Julia Brun et al. PLoS One
- Consolidation of first-line therapy with busulphan and melphalan and autologous stem cell rescue in children with Ewing’s sarcoma
- (2012) K Drabko et al. BONE MARROW TRANSPLANTATION
- The ganglioside antigen GD2 is surface-expressed in Ewing sarcoma and allows for MHC-independent immune targeting
- (2012) S Kailayangiri et al. BRITISH JOURNAL OF CANCER
- A TARBP2-Dependent miRNA Expression Profile Underlies Cancer Stem Cell Properties and Provides Candidate Therapeutic Reagents in Ewing Sarcoma
- (2012) Claudio De Vito et al. CANCER CELL
- Phase II study of cisplatin and oral VP16 in patients with refractory or relapsed Ewing sarcoma
- (2012) Cormac Owens et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- PARP-1 Inhibition as a Targeted Strategy to Treat Ewing's Sarcoma
- (2012) J. C. Brenner et al. CANCER RESEARCH
- Small-molecule screen identifies modulators of EWS/FLI1 target gene expression and cell survival in Ewing's sarcoma
- (2012) Aleksandar Boro et al. INTERNATIONAL JOURNAL OF CANCER
- Phase II Trial of Trastuzumab in Combination With Cytotoxic Chemotherapy for Treatment of Metastatic Osteosarcoma With Human Epidermal Growth Factor Receptor 2 Overexpression: A Report From the Children's Oncology Group
- (2012) David Ebb et al. JOURNAL OF CLINICAL ONCOLOGY
- Randomized Controlled Trial of Interval-Compressed Chemotherapy for the Treatment of Localized Ewing Sarcoma: A Report From the Children's Oncology Group
- (2012) Richard B. Womer et al. JOURNAL OF CLINICAL ONCOLOGY
- Identification of Common and Distinctive Mechanisms of Resistance to Different Anti-IGF-IR Agents in Ewing's Sarcoma
- (2012) Cecilia Garofalo et al. MOLECULAR ENDOCRINOLOGY
- Phase II Study of Sequential Gemcitabine Followed by Docetaxel for Recurrent Ewing Sarcoma, Osteosarcoma, or Unresectable or Locally Recurrent Chondrosarcoma: Results of Sarcoma Alliance for Research Through Collaboration Study 003
- (2012) E. Fox et al. ONCOLOGIST
- Initial testing of the MDM2 inhibitor RG7112 by the pediatric preclinical testing program
- (2012) Hernan Carol et al. PEDIATRIC BLOOD & CANCER
- Redirecting T Cells to Ewing's Sarcoma Family of Tumors by a Chimeric NKG2D Receptor Expressed by Lentiviral Transduction or mRNA Transfection
- (2012) Manfred Lehner et al. PLoS One
- Results of the Scandinavian Sarcoma Group XIV protocol for classical osteosarcoma
- (2011) Sigbjørn Smeland et al. Acta Orthopaedica
- Proton-based radiotherapy for unresectable or incompletely resected osteosarcoma
- (2011) I. Frank Ciernik et al. CANCER
- Immunotherapy targeting HER2 with genetically modified T cells eliminates tumor-initiating cells in osteosarcoma
- (2011) N Rainusso et al. CANCER GENE THERAPY
- Excellent Prognosis in a Subset of Patients with Ewing Sarcoma Identified at Diagnosis by CD56 Using Flow Cytometry
- (2011) S. Ash et al. CLINICAL CANCER RESEARCH
- A zebrafish transgenic model of Ewing's sarcoma reveals conserved mediators of EWS-FLI1 tumorigenesis
- (2011) S. W. Leacock et al. Disease Models & Mechanisms
- Anticancer effects of the p53 activator nutlin-3 in Ewing’s sarcoma cells
- (2011) Jürgen Sonnemann et al. EUROPEAN JOURNAL OF CANCER
- Chemotherapeutic adjuvant treatment for osteosarcoma: Where do we stand?
- (2011) Jakob K. Anninga et al. EUROPEAN JOURNAL OF CANCER
- A phase 2 trial of trabectedin in children with recurrent rhabdomyosarcoma, Ewing sarcoma and non-rhabdomyosarcoma soft tissue sarcomas: A report from the Children’s Oncology Group
- (2011) Sylvain Baruchel et al. EUROPEAN JOURNAL OF CANCER
- Oncogenic Fusion Protein EWS/FLI1 Down-regulates Gene Expression by Both Transcriptional and Posttranscriptional Mechanisms
- (2011) Kelly A. France et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- R1507, a Monoclonal Antibody to the Insulin-Like Growth Factor 1 Receptor, in Patients With Recurrent or Refractory Ewing Sarcoma Family of Tumors: Results of a Phase II Sarcoma Alliance for Research Through Collaboration Study
- (2011) Alberto S. Pappo et al. JOURNAL OF CLINICAL ONCOLOGY
- Preliminary Efficacy of the Anti-Insulin–Like Growth Factor Type 1 Receptor Antibody Figitumumab in Patients With Refractory Ewing Sarcoma
- (2011) Heribert Juergens et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase I/II Trial and Pharmacokinetic Study of Cixutumumab in Pediatric Patients With Refractory Solid Tumors and Ewing Sarcoma: A Report From the Children's Oncology Group
- (2011) Suman Malempati et al. JOURNAL OF CLINICAL ONCOLOGY
- miR-34a predicts survival of Ewing's sarcoma patients and directly influences cell chemo-sensitivity and malignancy
- (2011) Fumihiko Nakatani et al. JOURNAL OF PATHOLOGY
- Efficacy of Ganitumab (AMG 479), Alone and in Combination with Rapamycin, in Ewing's and Osteogenic Sarcoma Models
- (2011) P. J. Beltran et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Hsa-mir-145 is the top EWS-FLI1-repressed microRNA involved in a positive feedback loop in Ewing's sarcoma
- (2011) J Ban et al. ONCOGENE
- A novel oncogenic mechanism in Ewing sarcoma involving IGF pathway targeting by EWS/Fli1-regulated microRNAs
- (2011) E L McKinsey et al. ONCOGENE
- Efficacy of and resistance to anti-IGF-1R therapies in Ewing's sarcoma is dependent on insulin receptor signaling
- (2011) C Garofalo et al. ONCOGENE
- Small molecule inhibitors of ezrin inhibit the invasive phenotype of osteosarcoma cells
- (2011) G Bulut et al. ONCOGENE
- Clinical features and outcomes in patients with Ewing sarcoma and regional lymph node involvement
- (2011) Mark A. Applebaum et al. PEDIATRIC BLOOD & CANCER
- Initial testing of the CENP-E inhibitor GSK923295A by the pediatric preclinical testing program
- (2011) Richard B. Lock et al. PEDIATRIC BLOOD & CANCER
- Diagnostic accuracy of 18 F-FDG-PET and PET/CT in patients with Ewing sarcoma family tumours: a systematic review and a meta-analysis
- (2011) Giorgio Treglia et al. SKELETAL RADIOLOGY
- Addition of pamidronate to chemotherapy for the treatment of osteosarcoma
- (2010) Paul A. Meyers et al. CANCER
- Systemic administration of reovirus (Reolysin) inhibits growth of human sarcoma xenografts
- (2010) Pooja Hingorani et al. CANCER
- Zoledronic Acid as a New Adjuvant Therapeutic Strategy for Ewing's Sarcoma Patients
- (2010) G. A. Odri et al. CANCER RESEARCH
- Preclinical Evidence that Use of TRAIL in Ewing's Sarcoma and Osteosarcoma Therapy Inhibits Tumor Growth, Prevents Osteolysis, and Increases Animal Survival
- (2010) G. Picarda et al. CLINICAL CANCER RESEARCH
- Nutlin-3a Is a Potential Therapeutic for Ewing Sarcoma
- (2010) K. I. Pishas et al. CLINICAL CANCER RESEARCH
- NVP-BEZ235 as a New Therapeutic Option for Sarcomas
- (2010) M. C. Manara et al. CLINICAL CANCER RESEARCH
- Osteosarcoma
- (2010) Richard Gorlick et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Wnt Inhibitory Factor 1 Decreases Tumorigenesis and Metastasis in Osteosarcoma
- (2010) E. M. Rubin et al. MOLECULAR CANCER THERAPEUTICS
- Osteosarcoma incidence and survival rates from 1973 to 2004
- (2009) Lisa Mirabello et al. CANCER
- Nucleophosmin as a Candidate Prognostic Biomarker of Ewing's Sarcoma Revealed by Proteomics
- (2009) K. Kikuta et al. CLINICAL CANCER RESEARCH
- Ewing’s Sarcoma: Standard and Experimental Treatment Options
- (2009) Vivek Subbiah et al. CURRENT TREATMENT OPTIONS IN ONCOLOGY
- Notch signaling contributes to the pathogenesis of human osteosarcomas
- (2009) F. Engin et al. HUMAN MOLECULAR GENETICS
- Immunotherapy for Osteosarcoma: Genetic Modification of T cells Overcomes Low Levels of Tumor Antigen Expression
- (2009) Nabil Ahmed et al. MOLECULAR THERAPY
- A small molecule blocking oncogenic protein EWS-FLI1 interaction with RNA helicase A inhibits growth of Ewing's sarcoma
- (2009) Hayriye V Erkizan et al. NATURE MEDICINE
- Irinotecan and temozolomide for Ewing sarcoma: The Memorial Sloan-Kettering experience
- (2009) Denise A. Casey et al. PEDIATRIC BLOOD & CANCER
- The Increasing Complexity of the Cancer Stem Cell Paradigm
- (2009) J. M. Rosen et al. SCIENCE
- Combination of gemcitabine and docetaxel in the treatment of children and young adults with refractory bone sarcoma
- (2008) Fariba Navid et al. CANCER
- EWS-FLI-1 Expression Triggers a Ewing's Sarcoma Initiation Program in Primary Human Mesenchymal Stem Cells
- (2008) N. Riggi et al. CANCER RESEARCH
- EWS-FLI1 Induces Developmental Abnormalities and Accelerates Sarcoma Formation in a Transgenic Mouse Model
- (2008) Patrick P. Lin et al. CANCER RESEARCH
- Critical Role of Notch Signaling in Osteosarcoma Invasion and Metastasis
- (2008) P. Zhang et al. CLINICAL CANCER RESEARCH
- Second cancers in patients with the Ewing sarcoma family of tumours
- (2008) Fariba Navid et al. EUROPEAN JOURNAL OF CANCER
- Genetically defined EWS/FLI1 model system suggests mesenchymal origin of Ewing's family tumors
- (2008) Gary Potikyan et al. LABORATORY INVESTIGATION
- Whole Lung Irradiation in Patients with Exclusively Pulmonary Metastases of Ewing Tumors
- (2008) Tobias Bölling et al. STRAHLENTHERAPIE UND ONKOLOGIE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now